
<div id="jpedal" style="overflow: hidden; position: relative; width: 909px; height: 1195px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_3{left:64px;top:1156px;}
#t2_3{left:89px;top:1153px;}
#t3_3{left:97px;top:1156px;letter-spacing:0.4px;word-spacing:-0.1px;}
#t4_3{left:192px;top:1153px;}
#t5_3{left:199px;top:1156px;letter-spacing:-0.2px;word-spacing:0.5px;}
#t6_3{left:724px;top:1156px;letter-spacing:-0.1px;}
#t7_3{left:65px;top:84px;letter-spacing:0.1px;word-spacing:-2.7px;}
#t8_3{left:65px;top:102px;letter-spacing:0.1px;word-spacing:-2.5px;}
#t9_3{left:65px;top:120px;letter-spacing:1.2px;word-spacing:1.2px;}
#ta_3{left:65px;top:137px;letter-spacing:2.3px;word-spacing:2.9px;}
#tb_3{left:65px;top:154px;letter-spacing:0.4px;word-spacing:-0.1px;}
#tc_3{left:65px;top:172px;letter-spacing:0.8px;word-spacing:-0.2px;}
#td_3{left:65px;top:189px;letter-spacing:2.7px;word-spacing:3.4px;}
#te_3{left:65px;top:206px;letter-spacing:-0.5px;word-spacing:-1.8px;}
#tf_3{left:65px;top:224px;letter-spacing:0.9px;word-spacing:0.8px;}
#tg_3{left:65px;top:241px;letter-spacing:0.4px;word-spacing:-0.5px;}
#th_3{left:65px;top:258px;letter-spacing:1.7px;word-spacing:1.8px;}
#ti_3{left:65px;top:275px;letter-spacing:1.6px;word-spacing:1.6px;}
#tj_3{left:65px;top:293px;letter-spacing:1.1px;word-spacing:0.9px;}
#tk_3{left:65px;top:310px;letter-spacing:0.1px;word-spacing:-0.5px;}
#tl_3{left:65px;top:327px;word-spacing:-0.5px;}
#tm_3{left:65px;top:344px;letter-spacing:-0.7px;word-spacing:-2px;}
#tn_3{left:65px;top:362px;letter-spacing:-1px;word-spacing:-1.2px;}
#to_3{left:225px;top:363px;letter-spacing:-0.3px;}
#tp_3{left:235px;top:362px;letter-spacing:-0.7px;word-spacing:-1.8px;}
#tq_3{left:65px;top:379px;letter-spacing:0.2px;word-spacing:-0.5px;}
#tr_3{left:65px;top:396px;word-spacing:-1.8px;}
#ts_3{left:65px;top:413px;letter-spacing:0.2px;word-spacing:-1.3px;}
#tt_3{left:65px;top:431px;letter-spacing:1.1px;word-spacing:0.7px;}
#tu_3{left:232px;top:432px;letter-spacing:0.7px;}
#tv_3{left:244px;top:431px;letter-spacing:1px;word-spacing:0.7px;}
#tw_3{left:65px;top:448px;letter-spacing:3.7px;word-spacing:5.5px;}
#tx_3{left:65px;top:465px;letter-spacing:0.8px;word-spacing:-2px;}
#ty_3{left:283px;top:466px;letter-spacing:0.6px;}
#tz_3{left:295px;top:465px;letter-spacing:0.1px;}
#t10_3{left:65px;top:482px;letter-spacing:1.5px;word-spacing:1.2px;}
#t11_3{left:65px;top:500px;letter-spacing:0.4px;word-spacing:-1.2px;}
#t12_3{left:65px;top:517px;letter-spacing:0.8px;word-spacing:0.2px;}
#t13_3{left:65px;top:534px;letter-spacing:1.9px;word-spacing:1.2px;}
#t14_3{left:65px;top:552px;letter-spacing:1.6px;}
#t15_3{left:128px;top:553px;letter-spacing:1.1px;}
#t16_3{left:141px;top:552px;letter-spacing:1.8px;word-spacing:1.7px;}
#t17_3{left:65px;top:569px;letter-spacing:0.5px;word-spacing:-0.4px;}
#t18_3{left:65px;top:586px;letter-spacing:0.5px;word-spacing:-0.2px;}
#t19_3{left:65px;top:603px;letter-spacing:0.2px;word-spacing:-0.6px;}
#t1a_3{left:65px;top:621px;word-spacing:-0.6px;}
#t1b_3{left:65px;top:638px;letter-spacing:-0.1px;word-spacing:-1.4px;}
#t1c_3{left:230px;top:639px;letter-spacing:0.1px;}
#t1d_3{left:241px;top:638px;letter-spacing:-0.1px;word-spacing:-1.3px;}
#t1e_3{left:65px;top:655px;letter-spacing:1.4px;word-spacing:1.4px;}
#t1f_3{left:65px;top:672px;letter-spacing:0.9px;word-spacing:-0.9px;}
#t1g_3{left:65px;top:690px;letter-spacing:1.2px;word-spacing:0.3px;}
#t1h_3{left:65px;top:707px;letter-spacing:1.9px;word-spacing:2px;}
#t1i_3{left:65px;top:724px;letter-spacing:0.2px;word-spacing:-0.5px;}
#t1j_3{left:65px;top:741px;letter-spacing:0.8px;word-spacing:0.3px;}
#t1k_3{left:65px;top:759px;letter-spacing:2.6px;word-spacing:2.8px;}
#t1l_3{left:65px;top:776px;letter-spacing:0.1px;word-spacing:-0.5px;}
#t1m_3{left:65px;top:793px;letter-spacing:0.8px;word-spacing:0.3px;}
#t1n_3{left:65px;top:810px;letter-spacing:-0.4px;word-spacing:-1.8px;}
#t1o_3{left:65px;top:828px;letter-spacing:0.2px;word-spacing:-0.6px;}
#t1p_3{left:65px;top:845px;letter-spacing:0.7px;word-spacing:-0.3px;}
#t1q_3{left:157px;top:846px;letter-spacing:0.4px;}
#t1r_3{left:169px;top:845px;letter-spacing:0.2px;word-spacing:0.4px;}
#t1s_3{left:65px;top:862px;letter-spacing:1px;word-spacing:0.5px;}
#t1t_3{left:65px;top:880px;letter-spacing:0.7px;word-spacing:0.8px;}
#t1u_3{left:65px;top:897px;word-spacing:-1.9px;}
#t1v_3{left:65px;top:914px;word-spacing:-1.2px;}
#t1w_3{left:65px;top:948px;letter-spacing:0.1px;word-spacing:-2.5px;}
#t1x_3{left:65px;top:966px;letter-spacing:0.8px;word-spacing:0.4px;}
#t1y_3{left:65px;top:983px;letter-spacing:2.7px;word-spacing:3.7px;}
#t1z_3{left:65px;top:1000px;letter-spacing:0.8px;word-spacing:0.2px;}
#t20_3{left:65px;top:1018px;letter-spacing:1.3px;word-spacing:1.2px;}
#t21_3{left:65px;top:1035px;letter-spacing:2.8px;}
#t22_3{left:101px;top:1035px;letter-spacing:3px;}
#t23_3{left:132px;top:1036px;letter-spacing:1.6px;}
#t24_3{left:146px;top:1035px;letter-spacing:2.5px;word-spacing:3px;}
#t25_3{left:65px;top:1052px;letter-spacing:1.4px;word-spacing:1.2px;}
#t26_3{left:65px;top:1069px;letter-spacing:1.3px;word-spacing:-1.4px;}
#t27_3{left:65px;top:1087px;letter-spacing:1.4px;word-spacing:1.4px;}
#t28_3{left:65px;top:1104px;letter-spacing:0.8px;word-spacing:0.4px;}
#t29_3{left:333px;top:85px;letter-spacing:-0.1px;word-spacing:-1.3px;}
#t2a_3{left:333px;top:103px;letter-spacing:1.8px;word-spacing:2.1px;}
#t2b_3{left:333px;top:120px;letter-spacing:0.7px;word-spacing:0.2px;}
#t2c_3{left:333px;top:137px;letter-spacing:1.1px;word-spacing:0.8px;}
#t2d_3{left:333px;top:154px;letter-spacing:-0.2px;word-spacing:-1.8px;}
#t2e_3{left:485px;top:154px;letter-spacing:-0.1px;}
#t2f_3{left:494px;top:154px;}
#t2g_3{left:504px;top:154px;letter-spacing:-0.1px;word-spacing:-1.9px;}
#t2h_3{left:333px;top:172px;letter-spacing:1.4px;word-spacing:1.4px;}
#t2i_3{left:333px;top:189px;letter-spacing:0.5px;word-spacing:-0.5px;}
#t2j_3{left:333px;top:206px;letter-spacing:-0.4px;word-spacing:-1.8px;}
#t2k_3{left:333px;top:224px;letter-spacing:1.7px;word-spacing:1.6px;}
#t2l_3{left:333px;top:241px;letter-spacing:-0.3px;word-spacing:-1.1px;}
#t2m_3{left:346px;top:413px;letter-spacing:0.8px;word-spacing:0.9px;}
#t2n_3{left:478px;top:413px;letter-spacing:1px;}
#t2o_3{left:506px;top:414px;letter-spacing:0.7px;}
#t2p_3{left:518px;top:413px;letter-spacing:0.9px;}
#t2q_3{left:333px;top:431px;letter-spacing:0.5px;word-spacing:-0.3px;}
#t2r_3{left:333px;top:448px;letter-spacing:-0.4px;word-spacing:-1.7px;}
#t2s_3{left:333px;top:465px;letter-spacing:-0.6px;word-spacing:-1.8px;}
#t2t_3{left:333px;top:482px;letter-spacing:1.3px;word-spacing:0.9px;}
#t2u_3{left:333px;top:500px;letter-spacing:0.2px;}
#t2v_3{left:375px;top:501px;letter-spacing:0.6px;}
#t2w_3{left:387px;top:500px;letter-spacing:1px;word-spacing:0.5px;}
#t2x_3{left:333px;top:517px;letter-spacing:2.4px;word-spacing:3.1px;}
#t2y_3{left:333px;top:534px;letter-spacing:1.7px;word-spacing:-0.7px;}
#t2z_3{left:333px;top:552px;letter-spacing:-0.3px;word-spacing:-1.8px;}
#t30_3{left:333px;top:569px;letter-spacing:1.6px;word-spacing:1.3px;}
#t31_3{left:333px;top:586px;letter-spacing:2.3px;}
#t32_3{left:379px;top:587px;letter-spacing:1.4px;}
#t33_3{left:392px;top:586px;letter-spacing:2px;word-spacing:2.6px;}
#t34_3{left:333px;top:603px;letter-spacing:0.9px;word-spacing:0.6px;}
#t35_3{left:333px;top:621px;letter-spacing:0.8px;word-spacing:0.7px;}
#t36_3{left:462px;top:622px;letter-spacing:0.6px;}
#t37_3{left:474px;top:621px;letter-spacing:0.8px;word-spacing:0.6px;}
#t38_3{left:333px;top:638px;letter-spacing:-0.1px;word-spacing:-1.8px;}
#t39_3{left:333px;top:655px;letter-spacing:1.2px;word-spacing:1.1px;}
#t3a_3{left:333px;top:672px;letter-spacing:0.8px;word-spacing:0.6px;}
#t3b_3{left:333px;top:690px;letter-spacing:-0.2px;word-spacing:-1.9px;}
#t3c_3{left:531px;top:691px;}
#t3d_3{left:542px;top:690px;letter-spacing:0.1px;}
#t3e_3{left:333px;top:707px;word-spacing:-1.5px;}
#t3f_3{left:333px;top:724px;letter-spacing:0.7px;word-spacing:0.4px;}
#t3g_3{left:333px;top:741px;letter-spacing:0.5px;word-spacing:-0.4px;}
#t3h_3{left:333px;top:759px;letter-spacing:0.2px;word-spacing:-1.3px;}
#t3i_3{left:333px;top:793px;letter-spacing:0.1px;word-spacing:-2.5px;}
#t3j_3{left:333px;top:810px;letter-spacing:-0.5px;word-spacing:-1.6px;}
#t3k_3{left:333px;top:828px;letter-spacing:0.1px;word-spacing:-0.5px;}
#t3l_3{left:333px;top:845px;letter-spacing:1.9px;word-spacing:1.9px;}
#t3m_3{left:333px;top:862px;letter-spacing:2.3px;word-spacing:3.1px;}
#t3n_3{left:333px;top:880px;letter-spacing:1.1px;word-spacing:0.4px;}
#t3o_3{left:333px;top:897px;letter-spacing:0.6px;word-spacing:-0.3px;}
#t3p_3{left:333px;top:914px;letter-spacing:2.4px;word-spacing:3.1px;}
#t3q_3{left:333px;top:931px;letter-spacing:2.1px;word-spacing:2.6px;}
#t3r_3{left:333px;top:949px;letter-spacing:-0.2px;word-spacing:-0.1px;}
#t3s_3{left:333px;top:966px;letter-spacing:1.2px;word-spacing:1.3px;}
#t3t_3{left:333px;top:983px;letter-spacing:0.3px;word-spacing:-0.4px;}
#t3u_3{left:333px;top:1000px;letter-spacing:0.1px;word-spacing:-0.5px;}
#t3v_3{left:333px;top:1018px;letter-spacing:1.1px;word-spacing:0.7px;}
#t3w_3{left:333px;top:1035px;letter-spacing:-0.2px;word-spacing:-1px;}
#t3x_3{left:346px;top:1052px;letter-spacing:0.1px;word-spacing:-0.4px;}
#t3y_3{left:333px;top:1069px;letter-spacing:-0.2px;word-spacing:-1px;}
#t3z_3{left:333px;top:1087px;letter-spacing:1.5px;word-spacing:1.7px;}
#t40_3{left:333px;top:1104px;letter-spacing:0.5px;word-spacing:0.2px;}
#t41_3{left:602px;top:85px;letter-spacing:-0.3px;word-spacing:-1.8px;}
#t42_3{left:602px;top:103px;letter-spacing:0.6px;}
#t43_3{left:662px;top:103px;letter-spacing:0.6px;}
#t44_3{left:690px;top:104px;letter-spacing:0.5px;}
#t45_3{left:702px;top:103px;letter-spacing:0.7px;}
#t46_3{left:602px;top:120px;letter-spacing:1.7px;word-spacing:1.9px;}
#t47_3{left:602px;top:137px;letter-spacing:1px;word-spacing:0.3px;}
#t48_3{left:602px;top:154px;letter-spacing:0.2px;word-spacing:-0.4px;}
#t49_3{left:602px;top:172px;letter-spacing:1.5px;word-spacing:1.5px;}
#t4a_3{left:602px;top:189px;letter-spacing:1.3px;word-spacing:0.9px;}
#t4b_3{left:602px;top:206px;letter-spacing:0.7px;word-spacing:1.1px;}
#t4c_3{left:602px;top:224px;letter-spacing:-0.1px;word-spacing:-0.8px;}
#t4d_3{left:602px;top:241px;letter-spacing:1.6px;word-spacing:1.8px;}
#t4e_3{left:602px;top:258px;letter-spacing:2.1px;word-spacing:2.4px;}
#t4f_3{left:773px;top:259px;letter-spacing:1.4px;}
#t4g_3{left:786px;top:258px;letter-spacing:1.9px;word-spacing:2.6px;}
#t4h_3{left:602px;top:275px;letter-spacing:0.9px;word-spacing:0.3px;}
#t4i_3{left:602px;top:293px;letter-spacing:1.1px;word-spacing:0.6px;}
#t4j_3{left:602px;top:310px;letter-spacing:0.7px;word-spacing:0.1px;}
#t4k_3{left:602px;top:327px;letter-spacing:1.1px;word-spacing:0.5px;}
#t4l_3{left:836px;top:328px;letter-spacing:0.7px;}
#t4m_3{left:602px;top:344px;letter-spacing:1.6px;word-spacing:1.4px;}
#t4n_3{left:602px;top:362px;letter-spacing:2px;word-spacing:2.3px;}
#t4o_3{left:602px;top:379px;letter-spacing:0.2px;word-spacing:-0.6px;}
#t4p_3{left:811px;top:380px;letter-spacing:0.1px;}
#t4q_3{left:822px;top:379px;letter-spacing:0.1px;}
#t4r_3{left:602px;top:396px;letter-spacing:-0.2px;word-spacing:-1.8px;}
#t4s_3{left:602px;top:413px;letter-spacing:-0.4px;word-spacing:-2.5px;}
#t4t_3{left:602px;top:431px;letter-spacing:0.1px;word-spacing:-1.4px;}
#t4u_3{left:602px;top:448px;letter-spacing:-2.1px;}
#t4v_3{left:628px;top:449px;letter-spacing:-0.1px;}
#t4w_3{left:639px;top:448px;letter-spacing:-0.4px;word-spacing:-1.9px;}
#t4x_3{left:602px;top:465px;letter-spacing:-0.3px;word-spacing:-1.7px;}
#t4y_3{left:602px;top:482px;letter-spacing:-0.5px;word-spacing:-3.1px;}
#t4z_3{left:685px;top:482px;}
#t50_3{left:694px;top:482px;letter-spacing:-0.4px;word-spacing:-2px;}
#t51_3{left:602px;top:500px;letter-spacing:0.8px;word-spacing:0.3px;}
#t52_3{left:602px;top:517px;word-spacing:-1.8px;}
#t53_3{left:602px;top:534px;letter-spacing:-0.3px;word-spacing:-0.7px;}
#t54_3{left:679px;top:535px;letter-spacing:0.1px;}
#t55_3{left:690px;top:534px;word-spacing:-0.6px;}
#t56_3{left:602px;top:552px;letter-spacing:0.5px;word-spacing:-0.4px;}
#t57_3{left:602px;top:569px;letter-spacing:0.1px;word-spacing:-0.9px;}
#t58_3{left:602px;top:586px;letter-spacing:-0.1px;word-spacing:-1.1px;}
#t59_3{left:799px;top:587px;letter-spacing:0.1px;}
#t5a_3{left:615px;top:603px;letter-spacing:-0.6px;word-spacing:-2px;}
#t5b_3{left:602px;top:621px;letter-spacing:-0.5px;word-spacing:-1.8px;}
#t5c_3{left:602px;top:638px;letter-spacing:2.9px;word-spacing:4.1px;}
#t5d_3{left:803px;top:639px;letter-spacing:1.9px;}
#t5e_3{left:817px;top:638px;letter-spacing:2.3px;}
#t5f_3{left:602px;top:655px;letter-spacing:0.6px;word-spacing:-0.1px;}
#t5g_3{left:602px;top:672px;letter-spacing:0.6px;word-spacing:-0.7px;}
#t5h_3{left:602px;top:690px;letter-spacing:1px;word-spacing:0.7px;}
#t5i_3{left:602px;top:707px;letter-spacing:1px;word-spacing:0.8px;}
#t5j_3{left:602px;top:724px;letter-spacing:1.1px;word-spacing:1.7px;}
#t5k_3{left:602px;top:741px;letter-spacing:1.5px;word-spacing:0.2px;}
#t5l_3{left:602px;top:759px;letter-spacing:-0.2px;}
#t5m_3{left:629px;top:760px;letter-spacing:0.2px;}
#t5n_3{left:641px;top:759px;word-spacing:-0.3px;}
#t5o_3{left:602px;top:776px;letter-spacing:-0.2px;word-spacing:-1.7px;}
#t5p_3{left:602px;top:793px;letter-spacing:-0.7px;word-spacing:-1.8px;}
#t5q_3{left:602px;top:810px;letter-spacing:2.1px;word-spacing:0.6px;}
#t5r_3{left:602px;top:828px;letter-spacing:0.5px;}
#t5s_3{left:730px;top:829px;letter-spacing:0.4px;}
#t5t_3{left:741px;top:828px;letter-spacing:0.5px;}
#t5u_3{left:602px;top:845px;word-spacing:-1.8px;}
#t5v_3{left:602px;top:862px;letter-spacing:2.1px;word-spacing:2.6px;}
#t5w_3{left:813px;top:863px;letter-spacing:1.4px;}
#t5x_3{left:826px;top:862px;letter-spacing:0.4px;}
#t5y_3{left:602px;top:880px;letter-spacing:0.9px;word-spacing:0.4px;}
#t5z_3{left:602px;top:897px;letter-spacing:1.8px;word-spacing:2.3px;}
#t60_3{left:602px;top:914px;letter-spacing:0.9px;word-spacing:0.5px;}
#t61_3{left:602px;top:931px;letter-spacing:-0.1px;word-spacing:-1.2px;}
#t62_3{left:615px;top:949px;letter-spacing:0.3px;word-spacing:-0.2px;}
#t63_3{left:746px;top:949px;letter-spacing:0.3px;}
#t64_3{left:774px;top:950px;letter-spacing:0.3px;}
#t65_3{left:785px;top:949px;letter-spacing:0.5px;}
#t66_3{left:602px;top:966px;letter-spacing:1.7px;word-spacing:1.7px;}
#t67_3{left:602px;top:983px;letter-spacing:0.5px;}
#t68_3{left:602px;top:1000px;letter-spacing:1.5px;word-spacing:1.9px;}
#t69_3{left:602px;top:1018px;word-spacing:-0.3px;}
#t6a_3{left:602px;top:1035px;letter-spacing:0.7px;word-spacing:0.3px;}
#t6b_3{left:602px;top:1052px;letter-spacing:1.6px;word-spacing:0.6px;}
#t6c_3{left:602px;top:1069px;letter-spacing:2.4px;word-spacing:-1.5px;}
#t6d_3{left:602px;top:1087px;letter-spacing:-0.1px;word-spacing:-1.6px;}
#t6e_3{left:602px;top:1104px;word-spacing:-0.5px;}
#t6f_3{left:764px;top:1105px;letter-spacing:0.1px;}
#t6g_3{left:775px;top:1104px;letter-spacing:-0.3px;word-spacing:0.1px;}
#t6h_3{left:333px;top:253px;letter-spacing:-31.5px;}
#t6i_3{left:364px;top:279px;letter-spacing:-1px;word-spacing:-3.1px;}
#t6j_3{left:333px;top:302px;letter-spacing:-1px;word-spacing:-3.1px;}
#t6k_3{left:333px;top:325px;letter-spacing:-1.2px;word-spacing:-3px;}
#t6l_3{left:333px;top:348px;letter-spacing:-1px;word-spacing:-3px;}
#t6m_3{left:333px;top:371px;letter-spacing:-1px;word-spacing:-3.1px;}
#t6n_3{left:496px;top:353px;letter-spacing:-28.3px;}
#t6o_3{left:63px;top:20px;letter-spacing:4.8px;}
#t6p_3{left:330px;top:1175px;}

.s8_3{
	FONT-SIZE: 34.1px;
	FONT-FAMILY: CBIJIW-MinionPro-Regular3;
	color: rgb(35,31,32);
}

.s6_3{
	FONT-SIZE: 58.1px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Me3;
	color: rgb(35,31,32);
}

.s11_3{
	FONT-SIZE: 79.4px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Md3;
	color: rgb(123,97,151);
}

.s3_3{
	FONT-SIZE: 45.8px;
	FONT-FAMILY: CBIJIW-MinionPro-Medium3;
	color: rgb(35,31,32);
}

.s12_3{
	FONT-SIZE: 275px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Md3;
	color: rgb(123,97,151);
}

.s4_3{
	FONT-SIZE: 45.8px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Me3;
	color: rgb(35,31,32);
}

.s14_3{
	FONT-SIZE: 42.8px;
	FONT-FAMILY: LMHOVE-Whitney-Light3;
	color: rgb(35,31,32);
}

.s1_3{
	FONT-SIZE: 44.6px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-De3;
	color: rgb(35,31,32);
}

.s9_3{
	FONT-SIZE: 56.8px;
	FONT-FAMILY: CBIJIW-MinionPro-It3;
	color: rgb(35,31,32);
}

.s7_3{
	FONT-SIZE: 56.8px;
	FONT-FAMILY: CBIJIW-MinionPro-Regular3;
	color: rgb(35,31,32);
}

.s13_3{
	FONT-SIZE: 91.7px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Me3;
	color: rgb(123,97,151);
}

.s10_3{
	FONT-SIZE: 305.6px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-Md3;
	color: rgb(123,97,151);
}

.s2_3{
	FONT-SIZE: 52.7px;
	FONT-FAMILY: CBIJIW-MinionPro-Medium3;
	color: rgb(35,31,32);
}

.s5_3{
	FONT-SIZE: 61.1px;
	FONT-FAMILY: CBIJIW-ITCFranklinGothicStd-De3;
	color: rgb(35,31,32);
}

.v1_3{
	-webkit-transform: scale(0.108, 0.25);
	-ms-transform: scale(0.108, 0.25);
	-moz-transform: scale(0.108, 0.25);
	-o-transform: scale(0.108, 0.25);
}

.v2_3{
	-webkit-transform: scale(0.312, 0.25);
	-ms-transform: scale(0.312, 0.25);
	-moz-transform: scale(0.312, 0.25);
	-o-transform: scale(0.312, 0.25);
}

.v3_3{
	-webkit-transform: scale(0.225, 0.25);
	-ms-transform: scale(0.225, 0.25);
	-moz-transform: scale(0.225, 0.25);
	-o-transform: scale(0.225, 0.25);
}

</style>
<style id="fonts3" type="text/css" >

@font-face {
	font-family: CBIJIW-MinionPro-It3;
	src: url("3/fonts/CBIJIW-MinionPro-It.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-MinionPro-Regular3;
	src: url("3/fonts/CBIJIW-MinionPro-Regular.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-ITCFranklinGothicStd-Me3;
	src: url("3/fonts/CBIJIW-ITCFranklinGothicStd-Me.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-ITCFranklinGothicStd-Md3;
	src: url("3/fonts/CBIJIW-ITCFranklinGothicStd-Md.woff") format("woff");
}

@font-face {
	font-family: LMHOVE-Whitney-Light3;
	src: url("3/fonts/LMHOVE-Whitney-Light.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-MinionPro-Medium3;
	src: url("3/fonts/CBIJIW-MinionPro-Medium.woff") format("woff");
}

@font-face {
	font-family: CBIJIW-ITCFranklinGothicStd-De3;
	src: url("3/fonts/CBIJIW-ITCFranklinGothicStd-De.woff") format("woff");
}

</style>
<div id="t1_3" class="t s1_3">528</div>
<div id="t2_3" class="t v1_3 s2_3">|</div>
<div id="t3_3" class="t s3_3">SEPTEMBER 2014 </div>
<div id="t4_3" class="t v1_3 s2_3">|</div>
<div id="t5_3" class="t s3_3">VOLUME 11</div>
<div id="t6_3" class="t s4_3">www.nature.com/nrurol</div>
<div id="t7_3" class="t s5_3">TST and prostate cancer risk</div>
<div id="t8_3" class="t s6_3">In men without prostate cancer</div>
<div id="t9_3" class="t s7_3">If elevated testosterone levels are associ-</div>
<div id="ta_3" class="t s7_3">ated with an increased risk of prostate </div>
<div id="tb_3" class="t s7_3">cancer, analysis of data from clinical trials </div>
<div id="tc_3" class="t s7_3">performed to evaluate the efficacy of TST </div>
<div id="td_3" class="t s7_3">should provide useful insight into the </div>
<div id="te_3" class="t s7_3">relationship between TST and the incidence </div>
<div id="tf_3" class="t s7_3">of prostate cancer among men at histori-</div>
<div id="tg_3" class="t s7_3">cally average risk of this disease. With this </div>
<div id="th_3" class="t s7_3">in mind, a meta-analysis of 19 placebo- </div>
<div id="ti_3" class="t s7_3">controlled TST studies in men with low </div>
<div id="tj_3" class="t s7_3">or low–normal serum testosterone levels </div>
<div id="tk_3" class="t s7_3">found no statistically significant difference </div>
<div id="tl_3" class="t s7_3">in prostate cancer incidence, PSA levels, or </div>
<div id="tm_3" class="t s7_3">urinary symptom scores in men treated with </div>
<div id="tn_3" class="t s7_3">TST, compared with placebo.</div>
<div id="to_3" class="t s8_3">25</div>
<div id="tp_3" class="t s7_3">Pooled mean </div>
<div id="tq_3" class="t s7_3">testosterone levels for the men included in </div>
<div id="tr_3" class="t s7_3">these studies before therapy were 344 ng/dl </div>
<div id="ts_3" class="t s7_3">and 320 ng/dl for placebo and testosterone </div>
<div id="tt_3" class="t s7_3">treated groups, respectively;</div>
<div id="tu_3" class="t s8_3">25</div>
<div id="tv_3" class="t s7_3">after treat-</div>
<div id="tw_3" class="t s7_3">ment, mean testosterone levels were </div>
<div id="tx_3" class="t s7_3">339 ng/dl and 536 ng/dl, respectively.</div>
<div id="ty_3" class="t s8_3">25</div>
<div id="tz_3" class="t s7_3">In </div>
<div id="t10_3" class="t s7_3">both groups, the initial serum PSA level </div>
<div id="t11_3" class="t s7_3">was 1.3 ng/dl, and men in the TST cohorts </div>
<div id="t12_3" class="t s7_3">of the studies analysed had an increase in </div>
<div id="t13_3" class="t s7_3">PSA of only 0.3 ng/dl, on average, after </div>
<div id="t14_3" class="t s7_3">treatment.</div>
<div id="t15_3" class="t s8_3">25</div>
<div id="t16_3" class="t s7_3">This meta-analysis demon-</div>
<div id="t17_3" class="t s7_3">strated a pooled event rate for the diagno-</div>
<div id="t18_3" class="t s7_3">sis of prostate cancer of 8.3 and 9.2 events </div>
<div id="t19_3" class="t s7_3">per 1,000 patient-years for patients treated </div>
<div id="t1a_3" class="t s7_3">with placebo and testosterone, respectively </div>
<div id="t1b_3" class="t s7_3">(OR 1.09, 95% CI 0.48–2.49).</div>
<div id="t1c_3" class="t s8_3">25</div>
<div id="t1d_3" class="t s7_3">In addition, </div>
<div id="t1e_3" class="t s7_3">events constituting either an increase in </div>
<div id="t1f_3" class="t s7_3">serum PSA of ≥1.5 ng/ml or achievement </div>
<div id="t1g_3" class="t s7_3">of a PSA level &gt;4 ng/ml was identified at </div>
<div id="t1h_3" class="t s7_3">a frequency of 41.6 and 57.1 events per </div>
<div id="t1i_3" class="t s7_3">1,000 patient-years for the placebo-treated </div>
<div id="t1j_3" class="t s7_3">and testosterone-treated patients, respec-</div>
<div id="t1k_3" class="t s7_3">tively (OR 1.19, 95% CI 0.67–2.09). In </div>
<div id="t1l_3" class="t s7_3">addition, a review of seven published trials </div>
<div id="t1m_3" class="t s7_3">evaluating TST found the rate of prostate </div>
<div id="t1n_3" class="t s7_3">cancer in testosterone-treated patients to be </div>
<div id="t1o_3" class="t s7_3">similar to the rate observed in population-</div>
<div id="t1p_3" class="t s7_3">screening trials.</div>
<div id="t1q_3" class="t s8_3">26</div>
<div id="t1r_3" class="t s7_3">Together, these findings </div>
<div id="t1s_3" class="t s7_3">suggest that TST therapy has a limited, if </div>
<div id="t1t_3" class="t s7_3">any, clinically relevant effect on prostate-</div>
<div id="t1u_3" class="t s7_3">cancer risk in individuals with low–normal </div>
<div id="t1v_3" class="t s7_3">baseline testosterone levels. </div>
<div id="t1w_3" class="t s6_3">In men at risk of prostate cancer</div>
<div id="t1x_3" class="t s7_3">Patients with HGPIN detected in a single </div>
<div id="t1y_3" class="t s7_3">sextant prostate biopsy sample have a </div>
<div id="t1z_3" class="t s7_3">25–30% chance of a prostate cancer diag-</div>
<div id="t20_3" class="t s7_3">nosis upon subsequent biopsies. García- </div>
<div id="t21_3" class="t s7_3">Cruz </div>
<div id="t22_3" class="t s9_3">et al.</div>
<div id="t23_3" class="t s8_3">27</div>
<div id="t24_3" class="t s7_3">prospectively analysed 82 </div>
<div id="t25_3" class="t s7_3">men diagnosed with HGPIN, and found </div>
<div id="t26_3" class="t s7_3">a signifi cant positive correlation of both </div>
<div id="t27_3" class="t s7_3">low bioavailable—unbound or albumin-</div>
<div id="t28_3" class="t s7_3">bound (that is, testosterone not bound to </div>
<div id="t29_3" class="t s7_3">high-affinity testosterone-binding proteins </div>
<div id="t2a_3" class="t s7_3">such as sex hormone-binding globulin) </div>
<div id="t2b_3" class="t s7_3">—testosterone and low free serum testos-</div>
<div id="t2c_3" class="t s7_3">terone levels in serum with a subsequent </div>
<div id="t2d_3" class="t s7_3">prostate-cancer diagnosis (</div>
<div id="t2e_3" class="t s9_3">P </div>
<div id="t2f_3" class="t s7_3">=</div>
<div id="t2g_3" class="t s7_3">0.04 for both </div>
<div id="t2h_3" class="t s7_3">free and bioavailable testosterone). This </div>
<div id="t2i_3" class="t s7_3">finding provides further evidence indicat-</div>
<div id="t2j_3" class="t s7_3">ing that low serum testosterone, rather than </div>
<div id="t2k_3" class="t s7_3">high testosterone levels, might be a risk </div>
<div id="t2l_3" class="t s7_3">factor for prostate cancer.</div>
<div id="t2m_3" class="t s7_3">Additionally, Rhoden </div>
<div id="t2n_3" class="t s9_3">et al.</div>
<div id="t2o_3" class="t s8_3">28</div>
<div id="t2p_3" class="t s7_3">examined </div>
<div id="t2q_3" class="t s7_3">75 hypogonadal men treated with TST for </div>
<div id="t2r_3" class="t s7_3">12 months; all the men included underwent </div>
<div id="t2s_3" class="t s7_3">a prostate biopsy before beginning TST, and </div>
<div id="t2t_3" class="t s7_3">20 men had HGPIN based on this initial </div>
<div id="t2u_3" class="t s7_3">biopsy.</div>
<div id="t2v_3" class="t s8_3">28</div>
<div id="t2w_3" class="t s7_3">After a 1-year follow-up period, </div>
<div id="t2x_3" class="t s7_3">the investigators found no statistically </div>
<div id="t2y_3" class="t s7_3">signifi cant change in PSA levels in men </div>
<div id="t2z_3" class="t s7_3">with normal biopsy results versus men with </div>
<div id="t30_3" class="t s7_3">evidence of HGPIN in the initial biopsy </div>
<div id="t31_3" class="t s7_3">tissues.</div>
<div id="t32_3" class="t s8_3">28</div>
<div id="t33_3" class="t s7_3">One patient with HGPIN was </div>
<div id="t34_3" class="t s7_3">later found to have prostate cancer based </div>
<div id="t35_3" class="t s7_3">on an abnormal DRE.</div>
<div id="t36_3" class="t s8_3">28</div>
<div id="t37_3" class="t s7_3">The authors con-</div>
<div id="t38_3" class="t s7_3">cluded that hypogonadal men with HGPIN </div>
<div id="t39_3" class="t s7_3">on biopsy did not have an increased risk </div>
<div id="t3a_3" class="t s7_3">of prostate cancer after TST compared to </div>
<div id="t3b_3" class="t s7_3">men with a normal prostate biopsy.</div>
<div id="t3c_3" class="t s8_3">28</div>
<div id="t3d_3" class="t s7_3">These </div>
<div id="t3e_3" class="t s7_3">data suggest that TST does not increase the </div>
<div id="t3f_3" class="t s7_3">incidence of prostate cancer, even among </div>
<div id="t3g_3" class="t s7_3">individuals with a high-risk of developing </div>
<div id="t3h_3" class="t s7_3">the disease.</div>
<div id="t3i_3" class="t s6_3">In men treated for prostate cancer</div>
<div id="t3j_3" class="t s7_3">Much controversy regarding TST is focused </div>
<div id="t3k_3" class="t s7_3">on concerns over the safety of testosterone </div>
<div id="t3l_3" class="t s7_3">administration in men who have previ-</div>
<div id="t3m_3" class="t s7_3">ously been treated for prostate cancer. </div>
<div id="t3n_3" class="t s7_3">Considering the demographical similari-</div>
<div id="t3o_3" class="t s7_3">ties between patients with prostate cancer </div>
<div id="t3p_3" class="t s7_3">and hypogonadal men, that some men </div>
<div id="t3q_3" class="t s7_3">have both conditions is not surprising. </div>
<div id="t3r_3" class="t s7_3">Traditionally, patients with prostate cancer </div>
<div id="t3s_3" class="t s7_3">have been considered ineligible for TST, </div>
<div id="t3t_3" class="t s7_3">but studies published over the past decade </div>
<div id="t3u_3" class="t s7_3">suggest that TST for hypogonadism can be </div>
<div id="t3v_3" class="t s7_3">safe when given to carefully selected and </div>
<div id="t3w_3" class="t s7_3">monitored patients.</div>
<div id="t3x_3" class="t s7_3">Men can receive definitive treatment for </div>
<div id="t3y_3" class="t s7_3">prostate cancer with radical prostatectomy, </div>
<div id="t3z_3" class="t s7_3">or with brachytherapy or external beam </div>
<div id="t40_3" class="t s7_3">radiation therapy (EBRT). With regard to </div>
<div id="t41_3" class="t s7_3">patients treated with radical prostatectomy, </div>
<div id="t42_3" class="t s7_3">Pastuszak </div>
<div id="t43_3" class="t s9_3">et al.</div>
<div id="t44_3" class="t s8_3">29</div>
<div id="t45_3" class="t s7_3">retrospectively reviewed </div>
<div id="t46_3" class="t s7_3">103 hypogonadal patients who received </div>
<div id="t47_3" class="t s7_3">transdermal TST after surgical treatment </div>
<div id="t48_3" class="t s7_3">of prostate cancer between 2003 and 2011. </div>
<div id="t49_3" class="t s7_3">The authors also included 49 eugonadal </div>
<div id="t4a_3" class="t s7_3">patients also treated with radical prosta-</div>
<div id="t4b_3" class="t s7_3">tectomy, but not with TST, as a reference </div>
<div id="t4c_3" class="t s7_3">group, and categorized all patients as being </div>
<div id="t4d_3" class="t s7_3">at high risk or low risk of postoperative </div>
<div id="t4e_3" class="t s7_3">prostate-cancer recurrence.</div>
<div id="t4f_3" class="t s8_3">29</div>
<div id="t4g_3" class="t s7_3">High risk </div>
<div id="t4h_3" class="t s7_3">of recurrence was defined as postsurgical </div>
<div id="t4i_3" class="t s7_3">pathology findings of one or more of the </div>
<div id="t4j_3" class="t s7_3">following: Gleason score ≥8, positive sur-</div>
<div id="t4k_3" class="t s7_3">gical margins, or positive lymph nodes.</div>
<div id="t4l_3" class="t s8_3">29</div>
<div id="t4m_3" class="t s7_3">Overall, the TST and eugonadal control </div>
<div id="t4n_3" class="t s7_3">populations had similar proportions of </div>
<div id="t4o_3" class="t s7_3">high-risk patients (25% versus 30%).</div>
<div id="t4p_3" class="t s8_3">29</div>
<div id="t4q_3" class="t s7_3">The </div>
<div id="t4r_3" class="t s7_3">hypogonadal patients had an initial median </div>
<div id="t4s_3" class="t s7_3">serum testosterone level of 261 ng/dl, which </div>
<div id="t4t_3" class="t s7_3">increased to 460 ng/dl during the course of </div>
<div id="t4u_3" class="t s7_3">TST.</div>
<div id="t4v_3" class="t s8_3">29</div>
<div id="t4w_3" class="t s7_3">After a median follow-up duration of </div>
<div id="t4x_3" class="t s7_3">27.5 months, a small increase in serum PSA </div>
<div id="t4y_3" class="t s7_3">of 0.003 ng/dl (</div>
<div id="t4z_3" class="t s9_3">P</div>
<div id="t50_3" class="t s7_3">&lt;0.001) was detected in the </div>
<div id="t51_3" class="t s7_3">hypogonadal patients as a whole, with no </div>
<div id="t52_3" class="t s7_3">increase in PSA levels in the eugonadal ref-</div>
<div id="t53_3" class="t s7_3">erence group.</div>
<div id="t54_3" class="t s8_3">29</div>
<div id="t55_3" class="t s7_3">In the hypogonadal cohort, </div>
<div id="t56_3" class="t s7_3">four cases of biochemical recurrence were </div>
<div id="t57_3" class="t s7_3">observed, compared with eight cases in the </div>
<div id="t58_3" class="t s7_3">reference group of eugonadal men.</div>
<div id="t59_3" class="t s8_3">29</div>
<div id="t5a_3" class="t s7_3">TST in men who have previously received </div>
<div id="t5b_3" class="t s7_3">definitive brachytherapy for prostate cancer </div>
<div id="t5c_3" class="t s7_3">has been evaluated by Sarosdy.</div>
<div id="t5d_3" class="t s8_3">30</div>
<div id="t5e_3" class="t s7_3">This </div>
<div id="t5f_3" class="t s7_3">author studied 31 men with serum testos-</div>
<div id="t5g_3" class="t s7_3">terone levels of &lt;300 ng/dl and symptoms </div>
<div id="t5h_3" class="t s7_3">of hypogonadism, in whom TST was ini-</div>
<div id="t5i_3" class="t s7_3">tiated at least 6 months after brachyther-</div>
<div id="t5j_3" class="t s7_3">apy, with most patients receiving weekly </div>
<div id="t5k_3" class="t s7_3">200 mg injections of testosterone cypio-</div>
<div id="t5l_3" class="t s7_3">nate.</div>
<div id="t5m_3" class="t s8_3">30</div>
<div id="t5n_3" class="t s7_3">Patients were followed for a median </div>
<div id="t5o_3" class="t s7_3">of 5 years (range 1.5–9.0 years), with serum </div>
<div id="t5p_3" class="t s7_3">testosterone levels increasing from a median </div>
<div id="t5q_3" class="t s7_3">of 188 ng/dl before TST to 498 ng/dl at </div>
<div id="t5r_3" class="t s7_3">follow-up assessment.</div>
<div id="t5s_3" class="t s8_3">30</div>
<div id="t5t_3" class="t s7_3">One patient dem-</div>
<div id="t5u_3" class="t s7_3">onstrated a single rise in serum PSA, which </div>
<div id="t5v_3" class="t s7_3">was followed by a decline in PSA.</div>
<div id="t5w_3" class="t s8_3">30</div>
<div id="t5x_3" class="t s7_3">No </div>
<div id="t5y_3" class="t s7_3">signs of cancer recurrence were observed </div>
<div id="t5z_3" class="t s7_3">in this patient group and, therefore, no </div>
<div id="t60_3" class="t s7_3">patients stopped TST because of possible </div>
<div id="t61_3" class="t s7_3">or confirmed cancer recurrence.</div>
<div id="t62_3" class="t s7_3">In addition, Pastuszak </div>
<div id="t63_3" class="t s9_3">et al.</div>
<div id="t64_3" class="t s8_3">31</div>
<div id="t65_3" class="t s7_3">retrospec-</div>
<div id="t66_3" class="t s7_3">tively studied data from three men who </div>
<div id="t67_3" class="t s7_3">were treated with brachytherapy for pros-</div>
<div id="t68_3" class="t s7_3">tate cancer, as well as 10 men who were </div>
<div id="t69_3" class="t s7_3">treated with EBRT. All the men had symp-</div>
<div id="t6a_3" class="t s7_3">toms of hypogonadism and serum testos-</div>
<div id="t6b_3" class="t s7_3">terone levels of &lt;300 ng/dl, and 12 were </div>
<div id="t6c_3" class="t s7_3">sub sequently treated with transdermal </div>
<div id="t6d_3" class="t s7_3">testosterone whereas the remaining patient </div>
<div id="t6e_3" class="t s7_3">received testosterone pellets.</div>
<div id="t6f_3" class="t s8_3">31</div>
<div id="t6g_3" class="t s7_3">At a median </div>
<div id="t6h_3" class="t v2_3 s10_3">‘‘</div>
<div id="t6i_3" class="t s11_3">These data suggest that TST </div>
<div id="t6j_3" class="t s11_3">does not increase the incidence </div>
<div id="t6k_3" class="t s11_3">of prostate cancer, even among </div>
<div id="t6l_3" class="t s11_3">individuals with a high-risk of </div>
<div id="t6m_3" class="t s11_3">developing the disease</div>
<div id="t6n_3" class="t v2_3 s12_3">’’</div>
<div id="t6o_3" class="t v3_3 s13_3">PERSPECTIVES</div>
<div id="t6p_3" class="t s14_3">© 2014 Macmillan Publishers Limited. All rights reserved</div>

<div id="pg3Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg3"><object width="909" height="1195" data="3/3.svg" type="image/svg+xml" id="pdf3" style="width:909px; height:1195px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 242;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_3");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
